U.S. judge in Texas invalidates Allergan patents on Restasis
October 16, 2017 at 13:18 PM EDT
Oct 16 (Reuters) - A U.S. judge on Monday invalidated patents issued to Allergan Plc on its dry eye medicine Restasis, saying they covered ideas that were too obvious to protect.
